Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 16:05 ET | Source: Oculis Holding AG

Oculis Reports Q1 2025 Financial Results and Provides Company Update

The recent R&D Day (replay) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high...
April 01, 2025 04:00 ET | Source: Oculis Holding AG

Oculis to Host In-Person and Virtual R&D Day on Key Business Updates and the Development Plans for Privosegtor (OCS-05) in Acute Optic Neuritis and Beyond

ZUG, Switzerland, April 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing...
January 04, 2016 14:54 ET | Source: Commence Bio

Commence Bio Finalizes Corporate Identity Change From WibiWorks Therapeutics and Introduces New Website

SPARKS, MD--(Marketwired - January 04, 2016) - Reflecting the STaRT™ of something big in immunotherapy, Commence Bio, Inc. today announced the completion of its corporate name change transition...